Avego BioScience Capital
Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
- United States
- Canada
- Europe
Investment stages
- Seed
- Series A
Industries
- Biotech
- Healthcare
About
Avego BioScience Capital is a venture capital firm that invests in early-stage life science companies. Their mission is to support innovative enterprises that can significantly improve healthcare and patient outcomes. They focus on companies with strong leadership, groundbreaking science, and substantial market potential.
Avego BioScience Capital is a venture capital firm that invests in early-stage life science companies. Their mission is to support innovative enterprises that can significantly improve healthcare and patient outcomes. They focus on companies with strong leadership, groundbreaking science, and substantial market potential.
Investment Thesis
Avego BioScience Capital is a venture capital firm focused on investing in early-stage life science companies. They seek to identify and support innovative companies with the potential to transform healthcare and improve patient outcomes. The firm's investment criteria prioritize businesses with strong management teams, novel science, and large market opportunities.
Manager's Experience
The management team combines deep scientific and investment expertise. Key figures include Dr. Michael J. Sofia, a renowned scientist instrumental in developing Sovaldi® and co-founder of Pharmasset (acquired for $11B), and Dr. Ken K. Ren, a Founding Managing Partner with over 20 years of experience in healthcare investment and company building. Their collective background spans breakthrough drug discovery, entrepreneurship, and venture capital.
Team
Michael A. G. Korengold - Managing Partner
Guivarc'h Kersual - Partner
Michelle L. Doig - Partner
Portfolio
Not available